Vyome Holdings, Inc. (HIND) Stock Ticker
Market factors today
Unlock the full HIND picture
About Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
HIND stock facts
| Ticker symbol | HIND |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $14.3M |
| CEO | Venkateswarlu Nelabhotla |
| Employees | 18 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2016-10-06 |
| Website | www.vyometx.com |
What you can see for HIND on Tickr
Live HIND price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HIND report.
Rankings
FAQ
What is the ticker symbol for Vyome Holdings, Inc.?
The ticker symbol for Vyome Holdings, Inc. is HIND, listed on the NASDAQ Global Market.
What is HIND?
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.